BRIEF-European Commission approves once-daily olumiant tablets for treatment of rheumatoid arthritis
February 13, 2017 at 16:46 PM EST
* European Commission approves once-daily olumiant tablets for treatment of adults with moderate-to-severe active rheumatoid arthritis
